Publication Name	World Journal of Gastroenterology
Manuscript ID	21230
Country

Received	2015-07-01 18:25
Peer-Review Started	2015-07-04 22:51
To Make the First Decision	2015-08-26 09:47
Return for Revision	2015-08-31 15:05
Revised	2015-09-20 16:14
Second Decision	2015-10-12 09:02
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2015-10-20 09:57
Articles in Press	2015-10-20 09:57
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2015-11-03 10:10
Publish the Manuscript Online	2015-11-18 12:39

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Surgery
Manuscript Type	Editorial
Article Title	Gallbladder carcinoma: Prognostic factors and therapeutic options
Manuscript Source	Invited Manuscript
All Author List	Thorsten Oliver Goetze
Funding Agency and Grant Number
Corresponding Author	Dr. Thorsten Oliver Goetze, PD, Institut of Clinical Cancer Research, UCT-University Cancer Center Frankfurt, Krankenhaus Nordwest, Steinbacher Hohl 2-26, 60488 Frankfurt, Germany. thgoetze@aol.com
Key Words	Gallbladder carcinoma; Stage-adjusted therapy; Radical cholecystectomy; Gallbladder polyps; Cholecystitis; Gallstones; Laparoscopic cholecystectomy
Core Tip	The outcome of gallbladder carcinoma is poor. In patients with early-stage disease, a 5-year survival rate of 75% is possible. Stage-adjusted therapy is key for improving survival. Despite the theoretical risk factors of gallbladder malignancies, only a third of gallbladder carcinomas are recognized preoperatively, and radical re-resection in cases of incidental discoveries of incidental or occult gallbladder carcinomas is often crucial to complete a so called radical cholecystectomy. Unfortunately, there are diverse interpretations and practices regarding stage-adjusted therapy for gallbladder carcinoma patients. The current data suggest that more radical therapy is warranted.
Publish Date	2015-11-18 12:39
Citation	Goetze TO. Gallbladder carcinoma: Prognostic factors and therapeutic options. World J Gastroenterol 2015; 21(43): 12211-12217
URL	http://www.wjgnet.com/1007-9327/full/v21/i43/12211.htm
DOI	http://dx.doi.org/10.3748/wjg.v21.i43.12211

Full Article (PDF)	WJG-21-12211.pdf
Full Article (Word)	WJG-21-12211.doc
Manuscript File	21230-Review.docx
Answering Reviewers	21230-Answering reviewers.pdf
Audio Core Tip	21230-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	21230-Conflict-of-interest statement.pdf
Copyright License Agreement	21230-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate	21230-Language certificate.pdf
Peer-review Report	21230-Peer-review(s).pdf
Scientific Misconduct Check	21230-Scientific misconduct check.pdf
Scientific Editor Work List	21230-Scientific editor work list.pdf